| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 512.73 |
| Log P | RDKit | 6.98 |
| Topological polar surface area (Å2) | RDKit | 80.67 |
| Number of hydrogen bond acceptors | RDKit | 4 |
| Number of hydrogen bond donors | RDKit | 1 |
| Number of carbon atoms | RDKit | 32 |
| Number of heavy atoms | RDKit | 37 |
| Number of heteroatoms | RDKit | 5 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 9 |
| Stereochemical complexity | RDKit | 0.28 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 5 |
| Number of sp3 hybridized carbon atoms | RDKit | 27 |
| Shape complexity | RDKit | 0.84 |
| Number of rotatable bonds | RDKit | 3 |
| Number of aliphatic carbocycles | RDKit | 5 |
| Number of aliphatic heterocycles | RDKit | 0 |
| Number of aliphatic rings | RDKit | 5 |
| Number of aromatic carbocycles | RDKit | 0 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 0 |
| Total number of rings | RDKit | 5 |
| Number of saturated carbocycles | RDKit | 4 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 4 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 5 |
| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 2 |
| Lipinski’s rule of 5 filter | RDKit | Failed |
| Number of Ghose filter violations | RDKit | 4 |
| Ghose filter | RDKit | Failed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.403607 |
| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.56 |
| Solubility class [ESOL] | SwissADME | Poorly soluble |
| Solubility class [Silicos-IT] | SwissADME | Poorly soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | Low |
| Log Kp (Skin permeation, cm/s) | SwissADME | -5.12 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | No |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | Yes |
| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000711 | ENSG00000086696 | HSD17B2 | 3294 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001828 | ENSG00000172831 | CES2 | 8824 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000707 | ENSG00000117594 | HSD11B1 | 3290 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000065 | ENSG00000198848 | CES1 | 1066 | ChEMBL, NPASS |
| TAR_EXP_000709 | ENSG00000108786 | HSD17B1 | 3292 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000708 | ENSG00000176387 | HSD11B2 | 3291 | BindingDB, ChEMBL, NPASS |
